SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-11-290197
Filing Date
2011-11-01
Accepted
2011-11-01 12:09:28
Documents
10
Period of Report
2011-09-30
Filing Date Changed
2011-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d227339d10q.htm 10-Q 569088
2 SECTION 302 CEO CERTIFICATION d227339dex311.htm EX-31.1 10464
3 SECTION 302 CFO CERTIFICATION d227339dex312.htm EX-31.2 10342
4 SECTION 906 CEO AND CFO CERTIFICATION d227339dex321.htm EX-32.1 4457
  Complete submission text file 0001193125-11-290197.txt   2500676

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20110930.xml EX-101.INS 313164
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20110930.xsd EX-101.SCH 20169
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20110930_cal.xml EX-101.CAL 36662
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20110930_def.xml EX-101.DEF 27853
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20110930_lab.xml EX-101.LAB 173478
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20110930_pre.xml EX-101.PRE 112842
Mailing Address 5445 DTC PARKWAY P4 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY P4 GREENWOOD VILLAGE CO 80111 303-418-1000
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 111170350
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1